While the tumor expression levels of CEA in our late-stage cohort did not exhibit a statistically significant prognostic value (based on an ROC analysis), our findings are in line with existing evidence that suggests elevated CEA serum levels are associated with a poor response to chemotherapy and shorter survival times for patients with colorectal cancer [45]. This evidence concerns the gene CEACAM5 and neoplasm.